chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Chest pain, Myalgia
Clinical narrative: chest pain / Every now and then throughout the day, I have pain about my heart pocket / happens at least once a day; could also be Anxiety; muscle ache more significant starting the day after the second vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of CHEST PAIN (chest pain / Every now and then throughout the day, I have pain about my heart pocket / happens at least once a day), ANXIETY (could also be Anxiety) and MYALGIA (muscle ache more significant starting the day after the second vaccine) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CELECOXIB (CELEBREX) for Arthritis, AMLODIPINE, HYDROCHLOROTHIAZIDE and IRBESARTAN for Blood pressure high.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (muscle ache more significant starting the day after the second vaccine). On an unknown date, the patient experienced CHEST PAIN (chest pain / Every now and then throughout the day, I have pain about my heart pocket / happens at least once a day) and ANXIETY (could also be Anxiety). The patient was treated with MELOXICAM for Muscle ache, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (chest pain / Every now and then throughout the day, I have pain about my heart pocket / happens at least once a day), ANXIETY (could also be Anxiety) and MYALGIA (muscle ache more significant starting the day after the second vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: not received the second dose, even though she had been given a date for the second dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (not received the second dose, even though she had been given a date for the second dose) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (not received the second dose, even though she had been given a date for the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (not received the second dose, even though she had been given a date for the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided  Treatment information was not provided
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (right leg) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pain in extremity (right leg). At the time of the report, pain in extremity (right leg) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information reported. Sender's comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Muscle spasms
Clinical narrative: Severe back spasms; Shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and MUSCLE SPASMS (Severe back spasms) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced HERPES ZOSTER (Shingles). On 21-Jun-2021, the patient experienced MUSCLE SPASMS (Severe back spasms). The patient was treated with DIAZEPAM (VALIUM) for Spasms, at a dose of 1 dosage form and FENTANYL for Spasms, at a dose of 1 dosage form. At the time of the report, HERPES ZOSTER (Shingles) and MUSCLE SPASMS (Severe back spasms) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Feeling hot, Hypersensitivity, Myalgia
Clinical narrative: Allergic reaction; hot to touch over area; Edema; Swollen arm; Painful arm; increased cough; Rhinitis; Itching at injection site; Redness below the injection site; myalgia; arthralgia; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Painful arm), FEELING HOT (hot to touch over area), OEDEMA (Edema) and HYPERSENSITIVITY (Allergic reaction) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergic to omnicef), Drug allergy (Allergic to chlorhexidine), Asthma and Adhesive tape allergy. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for High cholesterol, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Seasonal allergy, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for Vitamin D deficiency, SPIRONOLACTONE, MONTELUKAST SODIUM (SINGULAIR) and UBIDECARENONE (CO Q-10) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Painful arm), OEDEMA (Edema), COUGH (increased cough), RHINITIS (Rhinitis), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE ERYTHEMA (Redness below the injection site), ARTHRALGIA (arthralgia) and PYREXIA (Fever). 24-Feb-2021, the patient experienced MYALGIA (myalgia). On an unknown date, the patient experienced FEELING HOT (hot to touch over area) and HYPERSENSITIVITY (Allergic reaction). The patient was treated with PARACETAMOL (TYLENOL) on 24-Feb-2021 at an unspecified dose and frequency and PREDNISONE at a dose of 20 milligram. On 08-Mar-2021, PAIN IN EXTREMITY (Painful arm), OEDEMA (Edema), COUGH (increased cough), RHINITIS (Rhinitis), VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE ERYTHEMA (Redness below the injection site) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING HOT (hot to touch over area) and HYPERSENSITIVITY (Allergic reaction) outcome was unknown and MYALGIA (myalgia), ARTHRALGIA (arthralgia) and PYREXIA (Fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   For asthma patient is using breo inhaler and albuterol inhaler.    This case was linked to MOD-2021-027960 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema, Pain in extremity, Peripheral swelling, Pyrexia, Rhinitis
Clinical narrative: Allergic reaction; hot to touch over area; Edema; Swollen arm; Painful arm; increased cough; Rhinitis; Itching at injection site; Redness below the injection site; myalgia; arthralgia; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Painful arm), FEELING HOT (hot to touch over area), OEDEMA (Edema) and HYPERSENSITIVITY (Allergic reaction) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergic to omnicef), Drug allergy (Allergic to chlorhexidine), Asthma and Adhesive tape allergy. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for High cholesterol, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Seasonal allergy, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for Vitamin D deficiency, SPIRONOLACTONE, MONTELUKAST SODIUM (SINGULAIR) and UBIDECARENONE (CO Q-10) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Painful arm), OEDEMA (Edema), COUGH (increased cough), RHINITIS (Rhinitis), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE ERYTHEMA (Redness below the injection site), ARTHRALGIA (arthralgia) and PYREXIA (Fever). 24-Feb-2021, the patient experienced MYALGIA (myalgia). On an unknown date, the patient experienced FEELING HOT (hot to touch over area) and HYPERSENSITIVITY (Allergic reaction). The patient was treated with PARACETAMOL (TYLENOL) on 24-Feb-2021 at an unspecified dose and frequency and PREDNISONE at a dose of 20 milligram. On 08-Mar-2021, PAIN IN EXTREMITY (Painful arm), OEDEMA (Edema), COUGH (increased cough), RHINITIS (Rhinitis), VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE ERYTHEMA (Redness below the injection site) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING HOT (hot to touch over area) and HYPERSENSITIVITY (Allergic reaction) outcome was unknown and MYALGIA (myalgia), ARTHRALGIA (arthralgia) and PYREXIA (Fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   For asthma patient is using breo inhaler and albuterol inhaler.    This case was linked to MOD-2021-027960 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Allergic reaction; hot to touch over area; Edema; Swollen arm; Painful arm; increased cough; Rhinitis; Itching at injection site; Redness below the injection site; myalgia; arthralgia; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Painful arm), FEELING HOT (hot to touch over area), OEDEMA (Edema) and HYPERSENSITIVITY (Allergic reaction) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Allergic to omnicef), Drug allergy (Allergic to chlorhexidine), Asthma and Adhesive tape allergy. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for High cholesterol, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Seasonal allergy, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for Vitamin D deficiency, SPIRONOLACTONE, MONTELUKAST SODIUM (SINGULAIR) and UBIDECARENONE (CO Q-10) for an unknown indication.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), PAIN IN EXTREMITY (Painful arm), OEDEMA (Edema), COUGH (increased cough), RHINITIS (Rhinitis), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE ERYTHEMA (Redness below the injection site), ARTHRALGIA (arthralgia) and PYREXIA (Fever). 24-Feb-2021, the patient experienced MYALGIA (myalgia). On an unknown date, the patient experienced FEELING HOT (hot to touch over area) and HYPERSENSITIVITY (Allergic reaction). The patient was treated with PARACETAMOL (TYLENOL) on 24-Feb-2021 at an unspecified dose and frequency and PREDNISONE at a dose of 20 milligram. On 08-Mar-2021, PAIN IN EXTREMITY (Painful arm), OEDEMA (Edema), COUGH (increased cough), RHINITIS (Rhinitis), VACCINATION SITE PRURITUS (Itching at injection site) and VACCINATION SITE ERYTHEMA (Redness below the injection site) had resolved. At the time of the report, PERIPHERAL SWELLING (Swollen arm), FEELING HOT (hot to touch over area) and HYPERSENSITIVITY (Allergic reaction) outcome was unknown and MYALGIA (myalgia), ARTHRALGIA (arthralgia) and PYREXIA (Fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   For asthma patient is using breo inhaler and albuterol inhaler.    This case was linked to MOD-2021-027960 (Patient Link).
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received an expired Moderna COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired Moderna COVID-19 vaccine) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired Moderna COVID-19 vaccine). On 21-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired Moderna COVID-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Musculoskeletal discomfort, Pain in extremity, Peripheral swelling
Clinical narrative: her leg is swollen; can barely walk; like ankle is broken, can barely walk; she began experiencing discomfort on the joints on her arms and elbows; excruciating pain on feet and ankle; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (she began experiencing discomfort on the joints on her arms and elbows), PAIN IN EXTREMITY (excruciating pain on feet and ankle), PERIPHERAL SWELLING (her leg is swollen), GAIT DISTURBANCE (can barely walk) and ARTHRALGIA (like ankle is broken, can barely walk) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B214 and 007B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (she began experiencing discomfort on the joints on her arms and elbows), PAIN IN EXTREMITY (excruciating pain on feet and ankle) and ARTHRALGIA (like ankle is broken, can barely walk). On an unknown date, the patient experienced PERIPHERAL SWELLING (her leg is swollen) and GAIT DISTURBANCE (can barely walk). The patient was treated with OXYCODONE HYDROCHLORIDE, OXYCODONE TEREPHTHALATE, PARACETAMOL (PERCOCET [OXYCODONE HYDROCHLORIDE;OXYCODONE TEREPHTHALATE;PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, MUSCULOSKELETAL DISCOMFORT (she began experiencing discomfort on the joints on her arms and elbows), PAIN IN EXTREMITY (excruciating pain on feet and ankle), PERIPHERAL SWELLING (her leg is swollen), GAIT DISTURBANCE (can barely walk) and ARTHRALGIA (like ankle is broken, can barely walk) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication are blood pressure medicine with very low dosage.   This case was linked to MOD-2021-230046 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm after first dose; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (sore arm after first dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart transplant (heart transplant patient   ).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm after first dose). The patient was treated with PARACETAMOL (TYLENOL) for Pain in arm, at a dose of 1 dosage form. At the time of the report, MYALGIA (sore arm after first dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitantly, the patient was taking steroid shots every 6 months. Patient reported she was on a lot of medication given this and did not list them.   This case was linked to MOD-2021-230116 (Patient Link).
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Second dose is outside of recommended interval from first dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose is outside of recommended interval from first dose) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose is outside of recommended interval from first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose is outside of recommended interval from first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not reported  Treatment information was not reported.   Reporter did not allow further contact
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nasopharyngitis, Night sweats
Clinical narrative: Cold after first vaccine; Chills after first vaccine; Night Sweats after first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of NIGHT SWEATS (Night Sweats after first vaccine), CHILLS (Chills after first vaccine) and NASOPHARYNGITIS (Cold after first vaccine) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022N20A) for COVID-19 vaccination.     No medication history was provided.     On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced NIGHT SWEATS (Night Sweats after first vaccine). On 07-Mar-2021, the patient experienced CHILLS (Chills after first vaccine). On 08-Mar-2021, the patient experienced NASOPHARYNGITIS (Cold after first vaccine). On 08-Mar-2021, NIGHT SWEATS (Night Sweats after first vaccine) had resolved. On 09-Mar-2021, CHILLS (Chills after first vaccine) had resolved. On 10-Mar-2021, NASOPHARYNGITIS (Cold after first vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was unknown Treatment information was unknown
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Product dose omission issue, Pyrexia
Clinical narrative: have not gotten second dose; fever; tiredness; muscle pain on my arm / body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain on my arm / body aches), PYREXIA (fever), FATIGUE (tiredness) and PRODUCT DOSE OMISSION ISSUE (have not gotten second dose) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Apr-2021, the patient experienced MYALGIA (muscle pain on my arm / body aches). On 07-Apr-2021, the patient experienced PYREXIA (fever) and FATIGUE (tiredness). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (have not gotten second dose). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 08-Apr-2021, MYALGIA (muscle pain on my arm / body aches), PYREXIA (fever) and FATIGUE (tiredness) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (have not gotten second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Inappropriate schedule of product administration, Pain in extremity
Clinical narrative: Second dose more than 35 days apart from the first dose; sore arm after second dose; Numbness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm after second dose), HYPOAESTHESIA (Numbness in the arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose more than 35 days apart from the first dose) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 27B21A0 and 031L20A) for COVID-19 vaccination.     The patient's past medical history included Heart transplant.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jun-2021, the patient experienced PAIN IN EXTREMITY (sore arm after second dose) and HYPOAESTHESIA (Numbness in the arm). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose more than 35 days apart from the first dose). The patient was treated with PARACETAMOL (TYLENOL) for Pain in extremity, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm after second dose) and HYPOAESTHESIA (Numbness in the arm) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose more than 35 days apart from the first dose) had resolved.            Concomitant medications include steroid shots every 6 months.    This case was linked to MOD-2021-230107 (Patient Link).
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac disorder, Inappropriate schedule of product administration
Clinical narrative: Patient did not receive 2nd dose between day 25-35 of 1st dose; Open heart surgery after the 1st dose; This spontaneous case was reported by an other caregiver and describes the occurrence of CARDIAC DISORDER (Open heart surgery after the 1st dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient did not receive 2nd dose between day 25-35 of 1st dose) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced CARDIAC DISORDER (Open heart surgery after the 1st dose). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient did not receive 2nd dose between day 25-35 of 1st dose). The patient was treated with Surgery for Cardiac disorder. At the time of the report, CARDIAC DISORDER (Open heart surgery after the 1st dose) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient did not receive 2nd dose between day 25-35 of 1st dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow up information received on 21-06-2021 contains No Significant information.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea
Clinical narrative: Chest pains; Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pains) and DYSPNOEA (Shortness of breath) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pains) and DYSPNOEA (Shortness of breath). At the time of the report, CHEST PAIN (Chest pains) and DYSPNOEA (Shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Adverse drug reaction
Clinical narrative: Report a side effect; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (Report a side effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (Report a side effect). At the time of the report, ADVERSE DRUG REACTION (Report a side effect) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications and treatment information were reported.
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Consumer wants to receive her second dose today which is day 47; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Consumer wants to receive her second dose today which is day 47) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Consumer wants to receive her second dose today which is day 47). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Consumer wants to receive her second dose today which is day 47) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment medications were provided No  Concomitant medications were provided
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Limb discomfort, Myalgia
Clinical narrative: Range of motion on the left arm; couldn't lift the arm up, cannot get it in the back pocket for about 2 weeks.; Soreness on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of JOINT RANGE OF MOTION DECREASED (Range of motion on the left arm), LIMB DISCOMFORT (couldn't lift the arm up, cannot get it in the back pocket for about 2 weeks.) and MYALGIA (Soreness on the left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, the patient experienced JOINT RANGE OF MOTION DECREASED (Range of motion on the left arm), LIMB DISCOMFORT (couldn't lift the arm up, cannot get it in the back pocket for about 2 weeks.) and MYALGIA (Soreness on the left arm). At the time of the report, JOINT RANGE OF MOTION DECREASED (Range of motion on the left arm), LIMB DISCOMFORT (couldn't lift the arm up, cannot get it in the back pocket for about 2 weeks.) and MYALGIA (Soreness on the left arm) outcome was unknown.            No concomitant medication were reported. No treatment details were reported.
Sex: M
Vaccine: COVID19
Symptoms: Stem cell transplant
Clinical narrative: I had stem  cell transplant on 3/8/2021; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Jun-2021 and was forwarded to Moderna on 20-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of STEM CELL TRANSPLANT (I had stem  cell transplant on 3/8/2021) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Multiple myeloma, Stem cell transplant on 08-Mar-2021 and Chemotherapy (Several months).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced STEM CELL TRANSPLANT (I had stem  cell transplant on 3/8/2021). At the time of the report, STEM CELL TRANSPLANT (I had stem  cell transplant on 3/8/2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications and Treatment information were reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dizziness, Dyspnoea, Fatigue
Clinical narrative: Shortness of breath; Chest pain; diaphoretic palms; fatigue; Nausea; dizzines; Arm Discomfort; Palpitations; muscle ache; CHILLS; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm Discomfort), PALPITATIONS (Palpitations), DIZZINESS (dizzines), HYPERHIDROSIS (diaphoretic palms) and DYSPNOEA (Shortness of breath) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Dysautonomia. Previously administered products included for an unreported indication: ALBUTEROL [SALBUTAMOL] (Albuterol inhaler 2 puffs PRN). Concurrent medical conditions included Asthma. Concomitant products included PROPRANOLOL for Dysautonomia.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced LIMB DISCOMFORT (Arm Discomfort), PALPITATIONS (Palpitations), MYALGIA (muscle ache) and CHILLS (CHILLS). On 11-Mar-2021, the patient experienced DIZZINESS (dizzines). On 14-Mar-2021, the patient experienced NAUSEA (Nausea). On 15-Mar-2021, the patient experienced FATIGUE (fatigue). On 05-May-2021, the patient experienced HYPERHIDROSIS (diaphoretic palms) and CHEST PAIN (Chest pain). On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, LIMB DISCOMFORT (Arm Discomfort), PALPITATIONS (Palpitations), DIZZINESS (dizzines), HYPERHIDROSIS (diaphoretic palms), DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain), NAUSEA (Nausea), MYALGIA (muscle ache), CHILLS (CHILLS) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2021: Follow up document received and contains No New Information
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Limb discomfort, Myalgia, Nausea, Palpitations
Clinical narrative: Shortness of breath; Chest pain; diaphoretic palms; fatigue; Nausea; dizzines; Arm Discomfort; Palpitations; muscle ache; CHILLS; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Arm Discomfort), PALPITATIONS (Palpitations), DIZZINESS (dizzines), HYPERHIDROSIS (diaphoretic palms) and DYSPNOEA (Shortness of breath) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Dysautonomia. Previously administered products included for an unreported indication: ALBUTEROL [SALBUTAMOL] (Albuterol inhaler 2 puffs PRN). Concurrent medical conditions included Asthma. Concomitant products included PROPRANOLOL for Dysautonomia.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced LIMB DISCOMFORT (Arm Discomfort), PALPITATIONS (Palpitations), MYALGIA (muscle ache) and CHILLS (CHILLS). On 11-Mar-2021, the patient experienced DIZZINESS (dizzines). On 14-Mar-2021, the patient experienced NAUSEA (Nausea). On 15-Mar-2021, the patient experienced FATIGUE (fatigue). On 05-May-2021, the patient experienced HYPERHIDROSIS (diaphoretic palms) and CHEST PAIN (Chest pain). On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, LIMB DISCOMFORT (Arm Discomfort), PALPITATIONS (Palpitations), DIZZINESS (dizzines), HYPERHIDROSIS (diaphoretic palms), DYSPNOEA (Shortness of breath), CHEST PAIN (Chest pain), NAUSEA (Nausea), MYALGIA (muscle ache), CHILLS (CHILLS) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2021: Follow up document received and contains No New Information
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Feeding disorder, Headache, Illness, Myalgia
Clinical narrative: sick; bedridden; able to eat; very high fever; body ache; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick), BEDRIDDEN (bedridden), FEEDING DISORDER (able to eat), PYREXIA (very high fever) and MYALGIA (body ache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced BEDRIDDEN (bedridden), FEEDING DISORDER (able to eat), PYREXIA (very high fever), MYALGIA (body ache), NAUSEA (nausea) and HEADACHE (headache). On an unknown date, the patient experienced ILLNESS (sick). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (sick), BEDRIDDEN (bedridden), FEEDING DISORDER (able to eat), PYREXIA (very high fever), MYALGIA (body ache), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.            No concomitant medications was reported by the reporter.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: sick; bedridden; able to eat; very high fever; body ache; nausea; headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (sick), BEDRIDDEN (bedridden), FEEDING DISORDER (able to eat), PYREXIA (very high fever) and MYALGIA (body ache) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced BEDRIDDEN (bedridden), FEEDING DISORDER (able to eat), PYREXIA (very high fever), MYALGIA (body ache), NAUSEA (nausea) and HEADACHE (headache). On an unknown date, the patient experienced ILLNESS (sick). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (sick), BEDRIDDEN (bedridden), FEEDING DISORDER (able to eat), PYREXIA (very high fever), MYALGIA (body ache), NAUSEA (nausea) and HEADACHE (headache) outcome was unknown.            No concomitant medications was reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: Spotting vaginal; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (Spotting vaginal) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VAGINAL HAEMORRHAGE (Spotting vaginal). At the time of the report, VAGINAL HAEMORRHAGE (Spotting vaginal) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported by reporter.  No treatment medication was reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow-up received on 09-JUL-2021 contains no significant information
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nasopharyngitis, Nausea, Night sweats
Clinical narrative: Nausea after Second Shot; Headache after Second Shot; Cold after first vaccine; Chills after first vaccine; Night sweats after first vaccine; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold after first vaccine), NIGHT SWEATS (Night sweats after first vaccine), NAUSEA (Nausea after Second Shot), HEADACHE (Headache after Second Shot) and CHILLS (Chills after first vaccine) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 002N20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced NIGHT SWEATS (Night sweats after first vaccine). On 07-Mar-2021, the patient experienced CHILLS (Chills after first vaccine). On 08-Mar-2021, the patient experienced NASOPHARYNGITIS (Cold after first vaccine). On 02-Apr-2021, the patient experienced NAUSEA (Nausea after Second Shot) and HEADACHE (Headache after Second Shot). On 08-Mar-2021, NIGHT SWEATS (Night sweats after first vaccine) had resolved. On 09-Mar-2021, CHILLS (Chills after first vaccine) had resolved. On 10-Mar-2021, NASOPHARYNGITIS (Cold after first vaccine) had resolved. On 02-Apr-2021, NAUSEA (Nausea after Second Shot) and HEADACHE (Headache after Second Shot) had resolved.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, Wrong product administered
Clinical narrative: Interchange of Product; Pain in left arm/ pain in hand; Pain in elbow; This spontaneous case was reported by a physician and describes the occurrence of WRONG PRODUCT ADMINISTERED (Interchange of Product), PAIN IN EXTREMITY (Pain in left arm/ pain in hand) and ARTHRALGIA (Pain in elbow) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jun-2021, the patient experienced WRONG PRODUCT ADMINISTERED (Interchange of Product), PAIN IN EXTREMITY (Pain in left arm/ pain in hand) and ARTHRALGIA (Pain in elbow). On 21-Jun-2021, WRONG PRODUCT ADMINISTERED (Interchange of Product), PAIN IN EXTREMITY (Pain in left arm/ pain in hand) and ARTHRALGIA (Pain in elbow) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The concomitant medications were not reported. The treatment information was not provided.  The action taken with mRNA 1273 with the events was considered as not applicable.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue
Clinical narrative: fatigue; achy joints; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-Jun-2021 and was forwarded to Moderna on 21-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and ARTHRALGIA (achy joints) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue) and ARTHRALGIA (achy joints). At the time of the report, FATIGUE (fatigue) and ARTHRALGIA (achy joints) outcome was unknown.            Concomitant medications were not reported.  Treatment information was not provided.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Reporter stated is he doesn't not want to speak about the case. He declined Further FU.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.   Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: some soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (some soreness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ALPHA LIPOIC ACID, GABAPENTIN, GLIMEPIRIDE, METFORMIN, METOPROLOL, ATORVASTATIN, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), COENZYME Q10 [UBIDECARENONE], VITAMIN D [VITAMIN D NOS] and VITAMIN B12 NOS for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (some soreness). At the time of the report, VACCINATION SITE PAIN (some soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-030683 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow-up received on 25-JUN-2021 does not contain any significant information
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: I got dizzy; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I got dizzy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (I got dizzy). At the time of the report, DIZZINESS (I got dizzy) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-231505.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue
Clinical narrative: fatigue; achy joints; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and ARTHRALGIA (achy joints) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (fatigue) and ARTHRALGIA (achy joints). At the time of the report, FATIGUE (fatigue) and ARTHRALGIA (achy joints) outcome was unknown.            Concomitant product use was not provided by the reporter.  No treatment information was provided.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow-up information received on 16-JUL-2021 contains non-significant information.